Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 3.380
+0.040 (1.20%)
Apr 29, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -250.14 | -211.23 | -203.51 | -325.73 | Upgrade
|
| Depreciation & Amortization | - | 33.96 | 35.67 | 31.3 | 30.84 | Upgrade
|
| Other Amortization | - | 0.62 | 0.57 | 0.48 | 0.75 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.04 | - | 0.08 | Upgrade
|
| Stock-Based Compensation | - | 11.84 | 23.91 | 21.28 | 32.7 | Upgrade
|
| Other Operating Activities | - | -106.25 | -90.5 | -52.53 | 7.56 | Upgrade
|
| Change in Accounts Receivable | - | -23.88 | 372.75 | -413.24 | -13.62 | Upgrade
|
| Change in Inventory | - | -82.04 | -42.72 | -1.9 | - | Upgrade
|
| Change in Accounts Payable | - | 2.88 | 38.27 | -0.01 | -2.51 | Upgrade
|
| Change in Unearned Revenue | - | - | 756.99 | 366.53 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -4.96 | 5.7 | 21.48 | -3.03 | Upgrade
|
| Operating Cash Flow | - | -417.97 | 889.37 | -230.11 | -272.98 | Upgrade
|
| Capital Expenditures | - | -2.83 | -9.74 | -4.56 | -20.2 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.07 | - | 0.07 | Upgrade
|
| Cash Acquisitions | - | - | - | -0.71 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1.03 | -0.1 | -22.91 | -6.39 | Upgrade
|
| Other Investing Activities | - | 13.9 | 17.85 | 23.42 | -41.71 | Upgrade
|
| Investing Cash Flow | - | 10.04 | 8.08 | -4.75 | -68.22 | Upgrade
|
| Long-Term Debt Issued | - | 133.15 | 200 | 28.92 | - | Upgrade
|
| Long-Term Debt Repaid | - | -44.26 | -135.74 | -18.36 | -16.48 | Upgrade
|
| Total Debt Repaid | - | -44.26 | -135.74 | -18.36 | -16.48 | Upgrade
|
| Net Debt Issued (Repaid) | - | 88.89 | 64.26 | 10.56 | -16.48 | Upgrade
|
| Issuance of Common Stock | - | 1.61 | 9.89 | 11 | 10.35 | Upgrade
|
| Other Financing Activities | - | -6.78 | -5.08 | -0.09 | - | Upgrade
|
| Financing Cash Flow | - | 83.72 | 69.07 | 21.48 | -6.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 3.13 | 3.68 | 28.78 | -9.52 | Upgrade
|
| Net Cash Flow | - | -321.07 | 970.19 | -184.61 | -356.85 | Upgrade
|
| Free Cash Flow | - | -420.8 | 879.63 | -234.67 | -293.18 | Upgrade
|
| Free Cash Flow Margin | - | -164.44% | 1148.19% | -1333.44% | - | Upgrade
|
| Free Cash Flow Per Share | - | -0.43 | 0.90 | -0.24 | -0.31 | Upgrade
|
| Cash Interest Paid | - | 6.78 | 5.08 | 0.09 | - | Upgrade
|
| Levered Free Cash Flow | - | -268.93 | 249.64 | -524.53 | -183.45 | Upgrade
|
| Unlevered Free Cash Flow | - | -263.55 | 254.58 | -522.24 | -180.98 | Upgrade
|
| Change in Working Capital | - | -107.99 | 1,131 | -27.13 | -19.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.